Merz, M. ., Jauch, A. ., Hielscher, T. ., Bochtler, T. ., Schönland, S. ., Seckinger, A. ., … Goldschmidt, H. . (2018). Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma. Blood Advances, 2(1), 1-9. https://doi.org/10.1182/bloodadvances.2017013334 (Original work published 2018)

Breitkreutz, I. ., Podar, K. ., -Vazquez, F. . , V, Wilhelm, S. ., Hayden, P. ., Anderson, K. ., & Raab, M. . (2018). The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma. Annals of Hematology. https://doi.org/10.1007/s00277-018-3237-5 (Original work published 2018)